Seamless Data Integration for Effective Decision-Making

The BizInt Smart Charts product family offers tailored solutions for creating, customizing, and delivering intellectual property (IP) reports and visualizations. The integration of Patsnap and BizInt Smart Charts ensures a smooth workflow for users to customize data exports and craft tabular reports within BizInt Smart Charts, seamlessly merging Patsnap Analytics data with other IP datasets in a user-friendly format.  

BizInt Smart Charts’ reporting and visualization tools simplify the complex process of analyzing and distributing patent information. By combining data from various databases into interactive reports, patent professionals gain actionable intelligence for IP surveillance, whitespace analysis, Freedom to Operate searches, and more. Leveraging Patsnap’s extensive patent database, of over 187 million patents, adds an extra layer of confidence to the analysis.   

This collaboration not only combines the strengths of Patsnap’s extensive patent database and BizInt Smart Charts’ advanced reporting and visualization tools, but also introduces a cross-platform functionality that streamlines workflows. This optimization empowers users to save valuable time and resources in their IP workflows. 

According to Haydn Evans, Patsnap’s Go-To-Market leader: “Joining forces with BizInt further elevates the innovation toolkit for Patsnap’s data-driven innovators, and we’re especially thrilled at the impact this cross-platform functionality will bring to our pharma and life science users in accelerating their drug landscaping and development capabilities. This is a glimpse into our ongoing commitment to streamline and supercharge the global innovation cycle by building tools for enterprises racing to get the best products to market.” 

Available Now – Streamline Your Patent Workflow! 

The BizInt Smart Charts and Patsnap integration is now live, offering patent professionals a unified platform designed to streamline workflows and enhance decision-making. For more information, schedule a consultation with one of our innovation experts today. 

The post Transforming Patent Intelligence: Patsnap Partners with BizInt Smart Charts appeared first on Patsnap.

Introducing Family Search Mode! Explore the power of Patsnap’s Analytics tool like never before.

You can now conduct patent searches that treat each patent family as a unit of data. By shifting the focus away from isolated patent records to comprehensive patent families, you can delve into a realm where innovation is interconnected and extends beyond individual concepts.  

This innovative search approach empowers you to easily discern how elements within a patent family contribute to the overarching narrative of technological advancement. It proves instrumental in reinforcing crucial searches like freedom to operate, playing a pivotal role in unveiling the comprehensive scope of an invention. The outcome? Significantly enhanced quality and depth in your patent analysis, offering a more nuanced and insightful perspective into the realm of intellectual property.  

That’s not all! With Family Search Mode, you will gain instant access to a robust suite of family-level analysis tools, meticulously designed for unlocking family-level intelligence – all in record time! From our newly crafted Family Overview Page to family-wide custom field tagging – unlocking insights on patent families is now easier than ever! 

About Patsnap

Founded in 2007, Patsnap is the company behind the world’s leading AI-powered innovation intelligence platform. Patsnap provides global businesses with a connected, easy-to-use platform that helps them make better decisions in the innovation process. Customers are innovators across multiple industry sectors, including agriculture and chemicals, consumer goods, food and beverage, life sciences, automotive, oil and gas, professional services, aviation and aerospace, and education.   

Media Contact:     

Kate White

Email: kwhite@patsnap.com

The post Patsnap’s Analytics Launches Family Mode Searching appeared first on Patsnap.

At the recent Growth Industry Conference (GRIC) 2023 held in Tokyo, Guan Dian, Patsnap’s co-founder, unveiled the company’s strategic plans in Japan for the future. GRIC 2023 is Japan’s largest hybrid global conference and community specializing in the growth industry with the goal of elevating the country’s startup ecosystem to global standards.

During a panel session at the conference moderated by Nikkei’s Tsubasa Suruga, Guan and Carmen Yuen, general partner of Vertex Ventures Southeast Asia and India, shared more on Patsnap’s global strategy ahead. Vertex Ventures is one of the early backers of the Singapore-founded tech unicorn.

Reiterating Patsnap’s commitment to the Japanese market and underscoring the soaring demand for data integrity from Japanese clients, Guan assured the audience that the global leader in innovation and intellectual property intelligence is geared to meet their requirements and needs.

To date, Patsnap has successfully acquired 150 corporate clients in Japan, bearing testimony to its strong presence in the top-tier corporate market.

Over the past two years, Japan has also emerged as Patsnap’s fastest-growing market, boasting an average annual growth rate of more than 100 per cent, according to Guan. Recognising Japan’s rich landscape of innovative companies and substantial investments in research and development, Patsnap plans to augment the local office to capitalise on the opportunities, as well as foster the generation of groundbreaking solutions in various industry sectors.

Guan added: “We are excited about furthering our investment in Japan and are looking to expand our team. This way, we can acquire more customers and enhance our capability to provide timely and customised services tailored to clients’ needs. The positive feedback and support from our customers fuel our determination to strengthen our presence in Japan, in order to ensure that we continue to meet and exceed the expectations of our growing client base.”

In the detailed discussion, Guan also elaborated on how Patsnap gained global recognition for utilising advanced AI technology to efficiently process vast amounts of information to support enterprises and individuals in discovering new opportunities in highly competitive environments.

For its current user base of more than 12,000 customers in 50 countries, the company serves as an indispensable resource for accessing market technology, competitive intelligence, and patent insights essential for guiding product development from ideation to successful commercialization.

For more information about Patsnap and its solutions, visit www.patsnap.com or click the link below.

About Patsnap

Founded in 2007, Patsnap is the company behind the world’s leading AI-powered innovation intelligence platform. Patsnap provides global businesses with a connected, easy-to-use platform that helps them make better decisions in the innovation process. Customers are innovators across multiple industry sectors, including agriculture and chemicals, consumer goods, food and beverage, life sciences, automotive, oil and gas, professional services, aviation and aerospace, and education. www.patsnap.com

View original content to download multimedia here.

The post Patsnap Makes Strong Foray into Japanese Market appeared first on Patsnap.

Overcoming these hurdles is no easy task, and why 96% of drugs never make it to market. But the tide is changing. Research that previously took years to complete can now be done in a matter of days or weeks. Technological advancements in AI and machine learning make it faster and more efficient for scientific researchers to identify antibodies, validate targets, and analyze chemical structures and unfamiliar sequences.  

In this article, we’ll explore how to use Patsnap’s Bio Sequence Database to explore the functionality and applicability of unknown sequences. To illustrate this process, we’ll take a closer look at AAV (adeno-associated virus) drug development, serving as a tangible example of how sequence exploration can be achieved. 

Jump to . . .

• What are AAVs? 
• What is AAV Drug Development? 
• How Does Patsnap Bio Accelerate Scientific R&D? 
• About Patsnap Bio

What are AAVs?

Adeno-associated viruses, commonly referred to as AAVs, are a class of small, non-enveloped viruses that have gained significant attention in the field of biotechnology and gene therapy. These viruses belong to the Parvoviridae family and are characterized by their ability to infect both dividing and non-dividing cells, making them particularly appealing vectors for delivering genetic material into host cells. 

AAVs are naturally occurring in humans and other animals, and they are generally considered non-pathogenic, meaning they do not cause significant disease in their natural state. This safety profile has made them a popular choice for gene therapy applications. 

Researchers have harnessed the unique properties of AAVs to develop a versatile platform for delivering therapeutic genes into target cells. By engineering these viruses to carry specific genetic payloads, scientists can use AAVs to replace or correct faulty genes, introduce therapeutic proteins, or modulate cellular functions. This approach holds tremendous promise for the treatment of a wide range of genetic disorders, including inherited diseases and genetic mutations responsible for various medical conditions. 

What is AAV Drug Development? 

Imagine AAVs as tiny “drug delivery trucks” at the molecular level. Scientists modify these AAVs to carry genetic instructions or therapeutic molecules to target cells within the body. Once these AAVs reach their destination, they release their cargo, which can include instructions to produce a beneficial protein, fix a genetic defect, or regulate cellular processes. 

AAV drug development has shown great promise in treating a wide range of medical conditions, especially genetic disorders. For example, in cases where a person has a faulty or missing gene that causes a disease, AAVs can be programmed to carry a corrected version of that gene and deliver it to the affected cells. This approach has the potential to provide long-lasting relief or even a cure for genetic diseases. 

AAVs can also be used to deliver therapeutic proteins directly to specific tissues or organs, making them a versatile tool for developing treatments for various diseases, including those that affect the nervous system, muscles, and organs. 

How Does Patsnap Bio Accelerate Scientific R&D? 

Now let’s explore how to use Patsnap’s AI-powered Bio platform to extract the insights you need for more efficient R&D. We’ll use the example of AAVs.  

Within our Bio database, the first step is straightforward — simply input the raw AAV9 sequence and apply filters to search for related sequences. The image below provides an example of what you should see on your end when you run this search.  

Next, select the “View Sources” option. This will provide you with an in-depth breakdown of the listed sequences for more comprehensive analysis.

To further enhance your query, simply incorporate specific keywords and target tissues when searching through the database. Using this approach, you can quickly identify core patent sequences that streamlines scientific R&D.

About Patsnap Bio

Patsnap Bio offers the most extensive sequence search platform within Patsnap’s suite of products. Merging AI with expert-curated data, it offers an in-depth analysis of protein and nucleotide sequences sourced from global patents, biological journals, and public databases. Key biological sequences receive manual annotations, highlighting structural changes, ensuring utmost accuracy and optimizing sequence retrieval efficiency. 

To get started, create an account today. Registration is free, so you have nothing to lose and so much insight to gain! 

The post Patsnap Bio: How to Investigate Sequence Functionality & Global Development appeared first on Patsnap.

AIPLA’s Annual Meeting brings other intellectual property experts, thought leaders, and legal professionals from around the world. It provides a platform for intellectual property practitioners to sharpen their skills with learning sessions and interactive discussions, and by nurturing new connections within the IP community. This year’s event will be centered around exploring the latest developments, emerging trends, and critical issues shaping the intellectual property landscape.

Across the three days at AIPLA 2023, Patsnap will be showcasing the latest developments to its flagship product, Patent Analytics. This innovative solution provides powerful IP intelligence, allowing clients to manage risk, identify new opportunities, and defend their innovations with real-time IP analytics.

With access to billions of data points, comprehensive search options, and industry-leading analysis and review tools, the product streamlines workflows and enhances collaboration within IP and technical teams. Plus, the newest version of Patent Analytics embraces AI-powered tools for automated patent indexing and analysis. These advanced capabilities include semantic analysis, text-to-image linking, and AI sorting.

With a global patent database that includes 181.2 million jurisdictions and daily updates, Patsnap offers an invaluable resource for intellectual property professionals. It also provides comprehensive legal data points, including legal status, estimated expiration dates, litigation, license, transfer, re-examination, and much more.

Patsnap is excited to continue sharing its commitment to advancing the field of intellectual property and providing cutting-edge tools to empower IP professionals at The AIPLA 2023 Annual Meeting.

“We’re really looking forward to being an exhibitor at the AIPLA Annual Meeting and to showcase Analytics,” said Jeffrey Tiong, CEO of Patsnap. “We’re proud to bring a wealth of IP intelligence to the fingertips of our clients to empower their decision making, and to continue to support innovators in the ever-evolving landscape of intellectual property.” 

Visit Patsnap at The AIPLA 2023 Annual Meeting to learn more about Analytics and discover the company’s full suite of products.  

To learn more about Patsnap, and how it enables users to extract relevant insights, make informed decisions, and accelerate innovation, visit www.patsnap.com  or request a demo with one of our innovation specialists. 

About Patsnap:

Founded in 2007, Patsnap is the company behind the world’s leading AI-powered innovation intelligence platform. Patsnap provides global businesses with a connected, easy-to-use platform that helps them make better decisions in the innovation process. Customers are innovators across multiple industry sectors, including agriculture and chemicals, consumer goods, food and beverage, life sciences, automotive, oil and gas, professional services, aviation and aerospace, and education.   
 

Media Contact:  

Angie Douvis 

Email: adouvis@patsnap.com  

The post Patsnap to spotlight latest IP Analytics Solution at the AIPLA 2023 Annual Meeting appeared first on Patsnap.

In this article, we’ll delve into each update and how they’ll help you improve sequence searching and streamline freedom to operate (FTO) searches.

Patsnap Bio Update #1: New Refinements

To provide you with a more refined search experience, we have introduced two additional filters within the pre-search preferences. These new filters, Alignment Direction and Chemically Modified, offer you enhanced control over your search parameters before receiving your results.

Patsnap Bio Update #2: Optimized Search Results Page

Taking our commitment to improving your searching experience a step further, we’ve unified the results pages into a single, streamlined interface. This enhancement enables you to seamlessly review both your sequences and documents on a single screen, optimizing your workflow and providing a consolidated view that enhances your overall efficiency.

Plus, we’ve added the convenience of displaying your query name and associated sequence body at the top of all result pages. This feature guarantees you never lose track of your search context, further enhancing your UX.

Patsnap Bio Update #3: New Analysis Tab

Our new analysis tab contains five charts designed to provide you with relevant insights and streamline R&D processes.

Use these charts to inform decision making and navigate the patent landscape with confidence.

Patsnap Bio Update #4: Improved Review Process

We’ve improved our review process, making it easier to differentiate between species and locate the appropriate targets of interest to you. 

Powered by AI and manual curation, Patsnap Bio connects millions of patent and non-patent sources to streamline search and analysis. To learn more, sign up for free.

The post Key Precision Updates in Patsnap Bio’s October Release appeared first on Patsnap.

The United Patent Court (UPC) is an international court, established by participating European Union (EU) Member States, that handles infringement and validity issues related to both Unitary Patents and European patents.

With the Unitary Patent (UP), the European Patent Office (EPO) provides uniform protection in up to 17 Member States under the ratified UPCA, allowing patent holders with an approved European patent to avoid extra fees.

This newly launched patent system complements existing patent pathways, providing an added option next to national and traditional European patents.

Although the purpose of the UPC is to simplify the process of protecting European patents, aiming to minimize costly litigation, there are still risks involved.

For example, if a lawsuit is unsuccessful, the patent holder might lose their patent rights across a majority of the EU due to that single litigation. Recognizing this risk, Article 83(3) of the UPCA allows applicants and owners of the traditional European patent the choice to “opt-out” of their application or patent from the court’s exclusive jurisdiction during the transition period. This period can be extended for an additional seven years, offering additional flexibility and safety to patent holders.

Status of the UPC in Patsnap

Understanding the legal jurisdiction of a patent is crucial for due diligence in innovation-driven patent research. To simplify this, Patsnap extracts and processes the “status of Unified Patent Court” field, which includes indicators such as “Opt-out registered,” “Opt out not registered,” “Withdrawal after opt-out,” and “Positive decision after unitary effect request.”

This enables users to swiftly discern whether a European patent falls under the exclusive domain of the UPC, is governed only by national courts, or has dual jurisdiction. For real-time insights, users can activate email alerts specific to this field, ensuring they’re always informed about European patent updates.

Impact on Legal Data of European Patent Member States

Patsnap performed deep processing of the European Patent Member States, enabling users to quickly access up-to-date legal statuses and supplementary protection certificate (SPC) information across 44 jurisdictions.

Importantly, European patents with unitary effects influence European Patent Member States. As such, states adopting the unitary effect validation are distinctly marked, differentiating them from countries using the traditional validation method.

As the new UPC system unfolds, bringing with it complex nuances, access to accurate, up-to-date patent data is important important than ever.

To learn more about Patsnap, and how it enables users to extract relevant insights, make informed decisions, and accelerate innovation, visit patsnap.com or request a demo with one of our innovation specialists.

The post Europe’s 10-Year Journey to its New Patent Framework: Unpacking UP and UPC appeared first on Patsnap.

Project Files is a 3-in-1 download feature, designed to automate the analysis of 100 records, extract vital information, and instantly generate an editable report for you. This all-in-one package also provides a compilation of the key patents you’ve gathered, as well as a record of the queries utilized to shape your searches. 

 All the information contained within Project Files can be quickly exported, making patent analysis easier than ever. To learn more about Project Files, or to try it out today, visit https://www.patsnap.com/request-a-demo/.  

About Patsnap   

Founded in 2007, Patsnap is the company behind the world’s leading AI-powered innovation intelligence platform. Patsnap provides global businesses with a connected, easy-to-use platform that helps them make better decisions in the innovation process. Customers are innovators across multiple industry sectors, including agriculture and chemicals, consumer goods, food and beverage, life sciences, automotive, oil and gas, professional services, aviation and aerospace, and education.      

Media Contact:     

Antasha Durbin     

Email: adurbin@patsnap.com 

The post Patsnap Releases 3-in-1 Project Files to Streamline FTO & Invalidity Searches  appeared first on Patsnap.

Patsnap aims to cater to critical data service needs in key scenarios such as Company Innovation, Investment Intelligence, and Pharmaceuticals R&D. Users can access these invaluable data products through various delivery methods, including API and Datafeed. Interested individuals can now register for free on the Patsnap Data Open Platform (https://open.patsnap.com) and effortlessly experience these data products online. 

This milestone marks a significant leap forward for Patsnap’s data services, unlocking the untapped value and application scenarios that data holds. Bian Fu, Chief Data Officer of Patsnap, emphasized the pivotal role of data in technological innovation, stating, “Data serves as the cornerstone and driving force behind innovation. Our objective is to empower more technology innovators, enabling them to harness the vast array of high-quality data offered by Patsnap to drive productivity, while ensuring data security. Through open data products, we strive to accelerate the development of innovation and business applications.” 

Comprehensive Data Types and Extensive Coverage 

Patsnap’s data products encompass over 140 data types across three categories, incorporating Patent Data, Bio Chemical Data, and Innovation Data. Notably, Patsnap offers specialized data products such as Patsnap Expanded Family, Patsnap Standardized Assignee, Patsnap Patent Value, Patsnap Classification System, as well as patent litigation, patent licensing data, and patent estimated expiration date data. Additionally, customized data portfolios can be tailored to meet specific enterprise requirements. 

The Patent Data covers 178 million patent data entries from 170 global patent offices. It includes legal status data from 108 offices, estimated expiration date data from 138 offices, patent license data from 66 offices, and patent transfer data from 27 offices, among other valuable information. 

Bio Chemical Data encompasses 790 million sequences and 490 million nucleotide and protein data points from 80 countries. It also incorporates 220 million chemical structures, featuring multinational chemical approval information and clinical trial data. The collection comprises 73,000 global new drugs, 44,000 targets, 16 million pharmaceutical-related patents, 62 million scientific literature sources, 810,000 clinical trials, and over 870,000 organization data entries. 

Innovation Data encompasses 121 million enterprises worldwide, 2.75 million research fund data entries, 4.14 million government funding data entries, 956 thousand market reports, 808 thousand corporate merger data entries, and 22 million news sources, among other vital resources. 

Leading Data Processing and Unmatched Quality 

Over the years, Patsnap has conducted extensive mining and processing of both domestic and foreign patent raw data. This includes extracting structured fields, images, and PDF files, as well as standardizing key fields such as applicant, number, and address to ensure comprehensive data coverage and association accuracy. As a result, Patsnap has obtained several deeply processed data sets to cater to diverse needs. 

The high-quality data products provided by Patsnap owe their excellence to the company’s industry-leading algorithm capabilities. Utilizing computer vision, machine learning, natural language processing, neural networks, OCR recognition, knowledge mapping, and large-scale modeling techniques, Patsnap processes and analyzes various data types. The data quality is thoroughly evaluated across seven dimensions, including accuracy, completeness, consistency, timeliness, compliance, comprehensiveness, and business professionalism. Additionally, Patsnap employs its self-developed Big Data monitoring and alert systems to gain insights, maintain control, and guarantee stability throughout the entire data production process. 

Patsnap’s system capabilities ensure robust network security, data security, and personal information protection. The company has successfully obtained ISO27001 certifications in these areas. 

Deep Cultivation of Key Scenarios: Investment Intelligence and Pharmaceuticals R&D 

As global industries undergo digital transformation, the demand for high-quality data applications in critical scenarios such as Investment Intelligence, Pharmaceuticals R&D, and Cooperative Innovation has witnessed significant growth. 

Within the Pharmaceuticals R&D realm, the need for big data support is particularly pronounced in drug target identification and evaluation, as well as in the creation and decision-making processes of new drug R&D projects. By providing pharmaceutical companies with extensive, high-quality data encompassing targets, drug company R&D pipelines, biological sequences, and other pertinent information, Patsnap plays a pivotal role in facilitating breakthroughs in new drug R&D and shortening drug development cycles. 

In the Cooperative Innovation domain, Patsnap not only supplies IP data for enterprise self-built big data information centers but also aids companies in achieving their goals of competition monitoring and patent operation through the comprehensive application of diverse data products. 

For Investment Intelligence purposes, Patsnap provides data support to investment institutions in areas such as predictive research and signal finding, ESG theme investment, fundamental analysis, stock selection and portfolio building, as well as investment target screening and elimination. 

To cater to the diverse data delivery requirements in different scenarios, Patsnap’s data products support multiple forms, including API and data packages. The API option is ideal for self-built system platforms, internal management system enhancements, and scenarios that demand continuous, real-time access to the latest data. Conversely, the data package option supports batch exports and periodic updates of historical data, catering to one-time scenarios such as self-built thematic libraries and subject research that require less frequent updates. 

The Patsnap Data Open Platform (open.patsnap.com) is now open for free registration, enabling users to easily access and experience the service platform. Following thorough processing, the high-quality and scarce data provided by Patsnap will bridge the gap in the market for insufficiently abundant and high-quality open source data. 

Additionally, 13 data products from three series, namely “Global Patent Data,” “Bio Chemical Data,” and “Innovation Data,” have been listed on the Shanghai Data Exchange, its International Board, and the Suzhou Bigdata Exchange, establishing them as integral components of the data element circulation market. Through the release of data products, Patsnap endeavors to unlock the value of data, offer insights, and provide decision support to an increasing number of science and technology innovators, thereby facilitating innovation breakthroughs in the fiercely competitive global market. 

The post Patsnap Fully Opens 140 Data Products to Meet Growing Data Service Demands appeared first on Patsnap.

Fortunately, there’s a solution.

This summer, Patsnap officially launched its “Degenerate Sequences” search function on its Bio platform. This marks the world’s first degenerate sequence alignment algorithm, built to identify “trillion-scale sequences” (these are the operators and degenerate symbols) in patents. In addition, it also helps users mitigate risks associated with overlooking sequences and freedom to operate (FTO) issues.

Patsnap Bio contains the world’s largest protein and nucleic acid sequence database. The insights are extracted from millions of literature sources, patents, and public domain databases.

It empowers users to:

☉ Identify the most relevant sequences with manual annotation of key biological sequences, enhanced metadata tagging, and efficient indexing of biologics and targets to sequences. 

☉ Improve collaboration as results are effortlessly shared among teams. As a result, stakeholders can easily generate comprehensive reports, compare sequence alignments, and more. 

☉ Redefine their biosequence FTO using Patsnap’s state-of-the-art Degenerate Sequence Search. This feature is powered by deep data processing techniques and exclusive search AI algorithms to eliminate the risk of sequence omissions in searches. 

☉ Simplify sequence searching with a multitude of scenario-based sequence retrieval options available on demand, including antibody, multi-sequence, motif, fragment and more. 

☉ Pinpoint the data needed utilizing more than 40 granular filters available and Patsnap’s unique Sequence Assistant that significantly reduces the time spent locating biological sequences in patents. 

How to Conduct Biosequence Sequence Search and Analysis in 4 Simple Steps

Step 1: Enter the Sequence of Interest

Step 2: Filter the results

Step 3: Analyze the Results

Step 4: Extract Relevant Insights

Patsnap Biosequence Sequence Search and Analysis Application Scenarios

◆ Accelerate bio-innovation 

Gain valuable insights into the potential functions of unknown sequences, explore new research activities, and stay up-to-date on global research and development.

◆ Keep a pulse on competitor activity

Conduct comprehensive biosequence landscape analysis to track competitors to see if they’re working on similar sequences or moving into new areas. 

◆ Validate novelty and FTO with ease 

Search with confidence utilizing the world’s most up-to-date, comprehensive sequence database.

◆ Identify sequences for therapeutic activities 

Discover global biological sequences aligned with your specific target/drug name or functional description and gain valuable insights into the latest development status through our advanced search and analysis platform.

About Patsnap:

Founded in 2007, Patsnap is the company behind the world’s leading AI-powered innovation intelligence platform. Patsnap provides global businesses with a connected, easy-to-use platform that helps them make better decisions in the innovation process.

Customers are innovators across multiple industry sectors, including agriculture and chemicals, consumer goods, food and beverage, life sciences, automotive, oil and gas, professional services, aviation and aerospace, and education.   

Media Contact:   Antasha Durbin 

Email: adurbin@patsnap.com  

The post How to Accelerate Your Biosequence Search and Analysis appeared first on Patsnap.